Protective effect of Thymic Humoral Factor on porcine serum-induced hepatic fibrosis and liver damage in Wistar rats
Journal Title: Annals of Hepatology - Year 2011, Vol 10, Issue 4
Abstract
Introduction. Immunomodulatory drugs have been reported to have anti-inflammatory and anti-fibrotic properties. Thymic Humoral Factor (THF), a peptide produced in the thymus, causes a potent immunomodulatory effect on different components of the immune system. Objective. To evaluate the effect of THF on different stages of liver damage and fibrosis induced in rats through the administration of porcine serum (PS).Material and methods. PS-induced liver fibrosis models serve as a primarily immunological mechanism in the development of liver damage and fibrosis. Results. The intraperitoneal administration of THF in rats with PS-induced liver damage produced a reduction of ALT and AST after 60 days. Histopathological changes in liver sections showed an improved histological appearance and lower % of fibrosis after 60 days in liver damaged rats that received THF treatment. Serum IL-6 levels were visibly reduced by THF administration after 60 days and in comparison with rats that did not receive the treatment. This was due to an increment in serum IL-10 levels caused by the administration of THF, which appears to reduce the inflammatory process by decreasing immune response. Conclusion. THF had beneficial effects in combating liver damage and fibrosis processes in an autoimmune model of PS-induced liver fibrosis in rats.
Authors and Affiliations
Ulises Osuna-Martínez, Jorge Reyes-Esparza, Vera Petricevich, Rogelio Hernández-Pando, Lourdes Rodríguez-Fragoso
Keywords
Related Articles
- EP ID EP78085
- DOI -
- Views 130
- Downloads 0
Prevalence and risk factors for bacterial skin infection and mortality in cirrhosis
Background. Bacterial infections are often associated with significant morbidity and mortality in cirrhosis. The common practice of outdoor barefoot walking in the developing world may predispose cirrhotic individuals to...
Abnormal liver function tests in a patient with myotonic dystrophy type 1
Myotonic dystrophy type 1, also known as Steinert’s disease, is a multisystemic disorder with significant genetic and clinical heterogeneity. Apart from skeletal muscles’ myotonia and wasting, a variety of system organs...
Cultural validation of the post-Liver transplant quality of life (pLTQ) questionnaire for the Brazilian population
Background and rationale. The post-Liver Transplant Quality of Life (pLTQ) questionnaire, developed in the United States, is adisease-targeted instrument designed to evaluate health-related quality of life (HRQoL) in li...
Prognostic markers in cirrhotic patients requiring intensive care: a comparative prospective study
Introduction. The use of prognostic models for cirrhotic patients admitted to the medical intensive care unit (ICU) is of great importance, since they provide an objective evaluation for a group of patients with high mo...
Hepatoblastoma. Clinical experience at a single institution using the Siopel staging system.
Background. Staging in Hepatoblastoma has recently become controversial. In developing countries diagnosis occurs mostly in advanced stages under these circumstances, we propose another option that can be considered of p...